The Trump administration negotiated MFN pricing deals with Novo Nordisk and Eli Lilly in November 2025, reducing Medicare/Medicaid prices for GLP-1 drugs to approximately $245/month ( [17] )
Clinical Trial Results: Tirzepatide (All Forms Mounjaro, Zepbound, Compounded): Because the active ingredient is identical, effectiveness is the same: SURMOUNT-1 Trial Results (72 weeks): 15 mg dose: 22.5% average body weight loss 10 mg dose: 21.4% average body weight loss 5 mg dose: 15.0% average body weight loss 96% of patients lost at least 5% of body weight 89% of patients lost at least 10% of body weight 63% of patients lost at least 20% of body weight Real-World Effectiveness: Compounded tirzepatide produces identical results to brand-name because its the same molecule at the same doses
For people with insurance coverage, there are usually multiple hoops to jump through, and each insurance companys prior authorization requirements are different, says Allison Rhodes, MD, an internal medicine and obesity medicine physician at the Ohio State University Wexner Medical Center in Columbus
Weight Loss DIFFERENCE BETWEEN SEMAGLUTIDE AND TIRZEPATIDE The main difference between semaglutide and tirzepatide is their mechanism: semaglutide activates only GLP-1 receptors, while tirzepatide activates both GLP-1 and GIP receptors, producing slightly more weight loss on average (20-25% vs 15-20% of body weight)